Expression of Connective Tissue Growth Factor Is Increased in Injured Myocardium Associated With Protein Kinase C β2 Activation and Diabetes
Kerrie J. Way(Harvard University), George L. King(Joslin Diabetes Center), Chris J. Vlahos(Eli Lilly (United States)), George E. Sandusky(Indiana University – Purdue University Indianapolis), Frederick J. Schoen(Brigham and Women's Hospital), Hisao Wakasaki(Brigham and Women's Hospital), Tamotsu Yokota(Joslin Diabetes Center), Kiyoshi Suzuma(Joslin Diabetes Center), Dmitriy Zvagelsky(Brigham and Women's Hospital), Penelope A. Pechous(Eli Lilly (United States)), Keiji Isshiki(Shiga University of Medical Science)
Cited by 180
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
|Journal of Biological Chemistry|1994|3.3k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k